Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission
about
Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaWho is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent eraUse of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationImpact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CRIn patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.Practice variation in physician referral for allogeneic hematopoietic cell transplantation.Cellular therapies in acute lymphoblastic leukemiaAutologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation ResearchIndications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.Upfront therapy of acute myeloid leukemia.Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it?Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.Redefining transplant in acute leukemia.Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EEfficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: a new prospect of exploiting extended family search.Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient.Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT.
P2860
Q28080943-4BD56C11-D07D-47A2-BDC5-B815921D1BA9Q30414156-CFACAD03-668D-45B8-B403-70A31F74FE29Q34749365-C8243808-17AC-4D2F-83F4-E69330C319E0Q34827332-34B806AB-F458-44FE-BCEB-325371B594A9Q34877613-7492D8AB-271A-4963-8EC1-2B543E788B4AQ34979564-3B248A12-9B26-4C67-B0DC-E25B2AA18776Q35060676-F574601F-68BF-4DD9-BA5B-D16147F98E15Q35772737-4248932C-042D-4C9A-A972-C1AC30619DF0Q36040293-8A014FA9-5321-425B-9CE6-6193FA2182DBQ36236659-653BA6EC-98F5-4526-8AEA-1D5DD2C401CBQ36547170-90CAC91A-A121-4339-BD18-098A330DC4F9Q36552098-929EC60C-A811-4D53-86C3-151212FE6DF9Q36579065-25A8DDA2-154B-4C3D-8CAB-A56C1134D213Q36794295-33DDABEE-7C87-4B5E-8D9E-D64FE5A677F6Q37249351-58D984BF-6587-458B-A027-B9A007D3C6CBQ37897183-70C6164D-A638-467F-B355-927A6FB1959AQ38199056-7A495A98-08B5-4592-820A-2A617FBC4D25Q38248427-A2E1035A-CE6C-4D1D-AEB6-C251924C3789Q38350274-BC8953FE-98BA-427E-B628-CC2683D6E940Q38657161-1B77A80E-448E-4E01-9EBD-1C9D73ECBF01Q38755378-02956C30-1B83-476C-B87B-A3BB4819B691Q38922475-B3529081-F5AF-4903-9D3A-D471AA0B4E41Q39972636-A605F193-9C82-4E8E-A8A8-1A03BB75FA1FQ40199108-3B9875F4-2712-4C19-8F5A-E95C73C253C9Q44331222-26AD5A02-558A-4298-A27F-D159012ABBE7Q44657508-7F0F5CBD-CD94-4F31-A591-A54F00CCAF7FQ45349920-8D08F884-430B-435D-ACF2-CB96C7B06B55Q46384069-15586684-FFA6-4B1B-ACEF-E3CE7C86AE0DQ46788345-17658359-D665-47E1-A196-BB795A35C6A4Q48232157-70729A1A-531D-449A-994D-D61C7EA00549Q48355093-DDE11609-5558-47A8-B0BB-6D68A0DF508AQ54212475-30D91A1A-0F3B-4C5E-888A-A23037D29758
P2860
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison of matched unrelate ...... id leukemia in first remission
@ast
Comparison of matched unrelate ...... id leukemia in first remission
@en
Comparison of matched unrelate ...... id leukemia in first remission
@nl
type
label
Comparison of matched unrelate ...... id leukemia in first remission
@ast
Comparison of matched unrelate ...... id leukemia in first remission
@en
Comparison of matched unrelate ...... id leukemia in first remission
@nl
prefLabel
Comparison of matched unrelate ...... id leukemia in first remission
@ast
Comparison of matched unrelate ...... id leukemia in first remission
@en
Comparison of matched unrelate ...... id leukemia in first remission
@nl
P2093
P2860
P356
P1433
P1476
Comparison of matched unrelate ...... id leukemia in first remission
@en
P2093
A E Woolfrey
A I Salter
E Lansverk
E W Petersdorf
F M Stewart
J A Hansen
M L Sorror
P V O'Donnell
R B Walter
P2860
P2888
P304
P356
10.1038/LEU.2010.102
P577
2010-05-20T00:00:00Z
P5875
P6179
1020924356